Postoperative Residual Curarization: A Case Report

  • Clay Freman, DNP, CRNA


An elderly frail male with a history of liver disease presented for a laparoscopic ablation of a liver mass. Nondepolarizing neuromuscular blockade agents were utilized to maintain a train-of-four count of 1 to 2 twitches throughout the surgery. At the conclusion of the operation the patient’s neuromuscular blockade was assessed via train-of-four at the corrugator supercilii and the patient was given neuromuscular blockade reversal agents. Approximately 10 minutes after arrival to the recovery unit, the patient presented with symptoms suggestive of postoperative residual curarization. This case report demonstrates the importance of objective assessment strategies when evaluating neuromuscular blockade. Monitoring twitches at the adductor pollicis at the end of surgery gives the practitioner better evidence of a more complete neuromuscular blockade recovery. Dosing and timing of neuromuscular blockade reversal agents is especially prudent to assure adequate patient recovery and safety postoperatively.

Author Biography

Clay Freman, DNP, CRNA
Dr Freeman was a student at Texas Christian University when this article was written.


1. Hukill SF, Griffin SL. Current attitudes related to the use of reversal agents after pharmacologic neuromuscular blockade. Webster University Department of Biological Sciences. 2008;1-26.
2. Plaud B. Neuromuscular monitoring, residual blockade, and reversal:
Time for re-evaluation of our clinical practice. Can J Anesth. 2013;60:634–40.
3. Kopman AF. Neuromuscular monitoring: Old issues, new controversies. Journal of Critical Care. 2009;24: 11–20.
4. Kopman AF, Eikerman M. Antagonism of non-depolarising neuromuscular block: current practice. Anaesthesia. 2009;64:22-30.
5. Hemmerling TM, Nhien L. Brief review: Neuromuscular monitoring: an update for the clinician. Can J Anesth. 2007;54:58–72.
6. Donati F. Residual paralysis: a real problem or did we invent a new disease? J Can Anesth. 2013;60:714–29.
7. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth & Anal. 2010;111(1):120-128.
8. Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth & Anal. 2010;111(1):129-140.
9. Welliver MD, Jones WH. Interdisciplinary intraoperative communication and collaboration needed for optimal neuromuscular blockade management. J Anaesth Clin Pharm. 2014;30(3):442-443.
10. Neft M, Quarashi JA, Greenier E. A closer look at the standards for nurse anesthesia practice. AANA Journal. 2013;81:92-6.
11. Hunter J. Antagonising neuromuscular block at the end of surgery. BMJ. 2012;1-2.
12. Lee PJ, MacLennan A, Naughton NN, et al. An analysis of reintubations
from a quality assurance database of 152,000 cases. J. Clin. Anesth. 2003;15:576-81.
How to Cite
FREMAN, DNP, CRNA, Clay. Postoperative Residual Curarization: A Case Report. Anesthesia eJournal, [S.l.], v. 4, n. 1, june 2016. ISSN 2333-2611. Available at: <>. Date accessed: 12 dec. 2018.